Odetti P - Search Results

1

Artificial neural networks identify the predictive values of risk factors on the conversion of amnestic mild cognitive impairment.

Tabaton M, Odetti P, Cammarata S, Borghi R, Monacelli F, Caltagirone C, Bossù P, Buscema M, Grossi E. Tabaton M, et al. Among authors: odetti p. J Alzheimers Dis. 2010;19(3):1035-40. doi: 10.3233/JAD-2010-1300. J Alzheimers Dis. 2010. PMID: 20157257

2

Plasma levels of insulin and amyloid beta 42 are correlated in patients with amnestic Mild Cognitive Impairment.

Odetti P, Piccini A, Giliberto L, Borghi R, Natale A, Monacelli F, Marchese M, Assini A, Colucci M, Cammarata S, Tabaton M. Odetti P, et al. J Alzheimers Dis. 2005 Dec;8(3):243-5. doi: 10.3233/jad-2005-8303. J Alzheimers Dis. 2005. PMID: 16340082

3

Amyloid-beta42 plasma levels are elevated in amnestic mild cognitive impairment.

Cammarata S, Borghi R, Giliberto L, Pardini M, Pollero V, Novello C, Fornaro M, Vitali A, Bracco L, Caltagirone C, Bossù P, Odetti P, Tabaton M. Cammarata S, et al. Among authors: odetti p. J Alzheimers Dis. 2009;18(2):267-71. doi: 10.3233/JAD-2009-1144. J Alzheimers Dis. 2009. PMID: 19584444

4

The H1 haplotype of the tau gene (MAPT) is associated with mild cognitive impairment.

Di Maria E, Cammarata S, Parodi MI, Borghi R, Benussi L, Galli M, Galimberti D, Ghidoni R, Gonella D, Novello C, Pollero V, Perroni L, Odetti P, Scarpini E, Binetti G, Tabaton M. Di Maria E, et al. Among authors: odetti p. J Alzheimers Dis. 2010;19(3):909-14. doi: 10.3233/JAD-2010-1285. J Alzheimers Dis. 2010. PMID: 20157246

5

Elevation of {beta}-amyloid 1-42 autoantibodies in the blood of amnestic patients with mild cognitive impairment.

Storace D, Cammarata S, Borghi R, Sanguineti R, Giliberto L, Piccini A, Pollero V, Novello C, Caltagirone C, Smith MA, Bossù P, Perry G, Odetti P, Tabaton M. Storace D, et al. Among authors: odetti p. Arch Neurol. 2010 Jul;67(7):867-72. doi: 10.1001/archneurol.2010.137. Arch Neurol. 2010. PMID: 20625095

6

Survival rate in patients affected by dementia followed by memory clinics (UVA) in Italy.

Ientile L, De Pasquale R, Monacelli F, Odetti P, Traverso N, Cammarata S, Tabaton M, Dijk B. Ientile L, et al. Among authors: odetti p. J Alzheimers Dis. 2013;36(2):303-9. doi: 10.3233/JAD-130002. J Alzheimers Dis. 2013. PMID: 23609761

7

Amnestic mild cognitive impairment and conversion to Alzheimer's disease: insulin resistance and glycoxidation as early biomarker clusters.

Monacelli F, Borghi R, Cammarata S, Nencioni A, Piccini A, Tabaton M, Odetti P. Monacelli F, et al. Among authors: odetti p. J Alzheimers Dis. 2015;45(1):89-95. doi: 10.3233/JAD-142511. J Alzheimers Dis. 2015. PMID: 25471189

8

Do Cancer Drugs Counteract Neurodegeneration? Repurposing for Alzheimer's Disease.

Monacelli F, Cea M, Borghi R, Odetti P, Nencioni A. Monacelli F, et al. Among authors: odetti p. J Alzheimers Dis. 2017;55(4):1295-1306. doi: 10.3233/JAD-160840. J Alzheimers Dis. 2017. PMID: 27834781 Review.

9

Frontal Variant of Alzheimer's Disease: A Report of a Novel PSEN1 Mutation.

Monacelli F, Martella L, Parodi MN, Odetti P, Fanelli F, Tabaton M. Monacelli F, et al. Among authors: odetti p. J Alzheimers Dis. 2019;70(1):11-15. doi: 10.3233/JAD-190363. J Alzheimers Dis. 2019. PMID: 31177233

10

Plasma levels of amyloid beta-protein 42 are increased in women with mild cognitive impairment.

Assini A, Cammarata S, Vitali A, Colucci M, Giliberto L, Borghi R, Inglese ML, Volpe S, Ratto S, Dagna-Bricarelli F, Baldo C, Argusti A, Odetti P, Piccini A, Tabaton M. Assini A, et al. Among authors: odetti p. Neurology. 2004 Sep 14;63(5):828-31. doi: 10.1212/01.wnl.0000137040.64252.ed. Neurology. 2004. PMID: 15365131

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

162 results

Search Page

Filters